Coronavirus Stock Market Opportunities

This Coronavirus Stock Market Forecast identifies the most affected stocks in negative way while also highlighting the opportunities arising in the stock market during these extraordinary market situation. The package covers the assets that may be affected by the coronavirus with the biggest financial exposures and it includes assets such as gold and relevant commodities, biotech companies’ stocks, pharmaceutical companies’ stocks, semiconductors and technological sectors stocks and more.

• Top 10 stocks for the long position
• Top 10 stocks for the short position

Package Name: Coronavirus Stock Market Forecast
Recommended Positions: Long
Forecast Length: 7 Days (7/1/2020 – 7/8/2020)
I Know First Average: 7.89%

9 out of 10 stock prices in this forecast for the Coronavirus Stock Market Forecast Package moved as predicted by the algorithm. The greatest return came from EBS at 19.38%. NVAX, and IAC had notable returns of 17.94% and 16.03%. The Coronavirus Stock Market Forecast package had an overall average return of 7.89%, providing investors with a premium of 5.64% over the S&P 500’s return of 2.25%.

Emergent BioSolutions, Inc., a specialty biopharmaceutical company, develops, manufactures, and sells specialized products to healthcare providers and governments in the United States and internationally. The company’s Biodefense division markets BioThrax to treat anthrax disease; Anthrasil for the treatment of inhalational anthrax; BAT to treat botulinum disease; VIGIV to address the adverse events from smallpox vaccination; and RSDL for the removal or neutralization of chemical agents, T-2 toxins, and various pesticide-related chemicals from the skin. This division is also developing NuThrax, a next generation anthrax vaccine; UV-4B for dengue and influenza infections; GC-072, the compound in the EV-035 series of broad spectrum antibiotics for Burkholderia pseudomallei; VAX161C, a recombinant pandemic influenza vaccine; and PreviThrax, a recombinant protective antigen anthrax vaccine, as well as other products addressing public health threats and emerging infectious diseases. Its Aptevo division markets IXINITY to prevent bleeding episodes in people with hemophilia B; WinRho SDF to treat autoimmune platelet disorders and hemolytic disease of the newborn; HepaGam B for the post-exposure prophylactic treatment of hepatitis-B; and VARIZIG for the post-exposure prophylactic treatment of varicella zoster virus. This division’s investigational stage product candidates include otlertuzumab, a protein therapeutic for Chronic Lymphocytic Leukemia; MOR209/ES414 for metastatic castration resistant prostate cancer under collaboration with MorphoSys AG; ES210, a protein therapeutic for inflammation-related indications; 5E3, a monoclonal antibody therapeutic for Alzheimer’s disease; and other protein therapeutic product candidates primarily for the treatment of immuno-oncology. In addition, the company provides contract manufacturing services to third-party customers. Emergent BioSolutions, Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.